198 related articles for article (PubMed ID: 19181472)
1. Evaluation of immunoassays for the measurement of insulin and C-peptide as indirect biomarkers of insulin misuse in sport: values in selected population of athletes.
Abellan R; Ventura R; Palmi I; di Carlo S; di Giovannandrea R; Bellver M; Olive R; Pascual JA; Pacifici R; Segura J; Zuccaro P; Pichini S
J Pharm Biomed Anal; 2009 Apr; 49(3):793-9. PubMed ID: 19181472
[TBL] [Abstract][Full Text] [Related]
2. Immunoassays for the measurement of IGF-II, IGFBP-2 and -3, and ICTP as indirect biomarkers of recombinant human growth hormone misuse in sport. Values in selected population of athletes.
Abellan R; Ventura R; Palmi I; di Carlo S; Bacosi A; Bellver M; Olive R; Pascual JA; Pacifici R; Segura J; Zuccaro P; Pichini S
J Pharm Biomed Anal; 2008 Nov; 48(3):844-52. PubMed ID: 18617352
[TBL] [Abstract][Full Text] [Related]
3. Effect of physical fitness and endurance exercise on indirect biomarkers of growth hormone and insulin misuse: Immunoassay-based measurement in urine samples.
Pichini S; Ventura R; Palmi I; di Carlo S; Bacosi A; Langohr K; Abellan R; Pascual JA; Pacifici R; Segura J; Zuccaro P
J Pharm Biomed Anal; 2010 Dec; 53(4):1003-10. PubMed ID: 20674210
[TBL] [Abstract][Full Text] [Related]
4. Effect of physical fitness and endurance exercise on indirect biomarkers of recombinant growth hormone misuse: insulin-like growth factor I and procollagen type III peptide.
Abellan R; Ventura R; Pichini S; Di Giovannandrea R; Bellver M; Olive R; Pacifici R; Pascual JA; Zuccaro P; Segura J
Int J Sports Med; 2006 Dec; 27(12):976-83. PubMed ID: 16612742
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of immunoassays for the measurement of erythropoietin (EPO) as an indirect biomarker of recombinant human EPO misuse in sport.
Abellan R; Ventura R; Pichini S; Remacha AF; Pascual JA; Pacifici R; Di Giovannandrea R; Zuccaro P; Segura J
J Pharm Biomed Anal; 2004 Sep; 35(5):1169-77. PubMed ID: 15336362
[TBL] [Abstract][Full Text] [Related]
6. Effect of physical fitness and endurance exercise on indirect biomarkers of recombinant erythropoietin misuse.
Abellan R; Ventura R; Pichini S; Palmi I; Bellver M; Olive R; Pacifici R; Pascual JA; Zuccaro P; Segura J
Int J Sports Med; 2007 Jan; 28(1):9-15. PubMed ID: 16804802
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of immunoassays for the measurement of insulin-like growth factor-I and procollagen type III peptide, indirect biomarkers of recombinant human growth hormone misuse in sport.
Abellan R; Ventura R; Pichini S; Pascual JA; Pacifici R; Di Carlo S; Bacosi A; Segura J; Zuccaro P
Clin Chem Lab Med; 2005; 43(1):75-85. PubMed ID: 15653447
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of immunoassays for the measurement of soluble transferrin receptor as an indirect biomarker of recombinant human erythropoietin misuse in sport.
Abellan R; Ventura R; Pichini S; Sarda MP; Remacha AF; Pascual JA; Palmi I; Bacosi A; Pacifici R; Zuccaro P; Segura J
J Immunol Methods; 2004 Dec; 295(1-2):89-99. PubMed ID: 15627614
[TBL] [Abstract][Full Text] [Related]
9. Performance characteristics of two immunoassays for the measurement of urinary luteinizing hormone.
Robinson N; Saudan C; Sottas PE; Mangin P; Saugy M
J Pharm Biomed Anal; 2007 Jan; 43(1):270-6. PubMed ID: 16884883
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of two immunoassays for the measurement of human chorionic gonadotropin in urine for anti-doping purposes.
Robinson N; Sottas PE; Saugy M
Clin Lab; 2010; 56(5-6):197-206. PubMed ID: 20575467
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of immunochemiluminometric assays for the measurement of insulin and C-peptide using the ADVIA Centaur.
El Kenz H; Bergmann P
Clin Lab; 2004; 50(3-4):171-4. PubMed ID: 15074471
[TBL] [Abstract][Full Text] [Related]
12. Analytical validation of a highly sensitive microparticle-based immunoassay for the quantitation of IL-13 in human serum using the Erenna immunoassay system.
St Ledger K; Agee SJ; Kasaian MT; Forlow SB; Durn BL; Minyard J; Lu QA; Todd J; Vesterqvist O; Burczynski ME
J Immunol Methods; 2009 Oct; 350(1-2):161-70. PubMed ID: 19732777
[TBL] [Abstract][Full Text] [Related]
13. Demographic factors influencing the GH system: Implications for the detection of GH doping in sport.
Nelson AE; Ho KK
Growth Horm IGF Res; 2009 Aug; 19(4):327-32. PubMed ID: 19481485
[TBL] [Abstract][Full Text] [Related]
14. Relation between serum creatinine and body mass index in elite athletes of different sport disciplines.
Banfi G; Del Fabbro M; Lippi G
Br J Sports Med; 2006 Aug; 40(8):675-8; discussion 678. PubMed ID: 16723402
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of a new fully automated one-step C-peptide chemiluminescence assay (LIAISON C-Peptid).
Pfützner A; Löbig M; Fortunato A; Forst T
Clin Lab; 2003; 49(5-6):227-32. PubMed ID: 15285178
[TBL] [Abstract][Full Text] [Related]
16. A luminescent oxygen channeling immunoassay for the determination of insulin in human plasma.
Poulsen F; Jensen KB
J Biomol Screen; 2007 Mar; 12(2):240-7. PubMed ID: 17259593
[TBL] [Abstract][Full Text] [Related]
17. Quantification of recombinant human parathyroid hormone (rhPTH(1-84)) in human plasma by immunoassay: commercial kit evaluation and validation to support pharmacokinetic studies.
Sukovaty RL; Lee JW; Fox J; Toney K; Papac DI; Grover TA; Wells DS
J Pharm Biomed Anal; 2006 Sep; 42(2):261-71. PubMed ID: 16765549
[TBL] [Abstract][Full Text] [Related]
18. Comparison of a luminescent oxygen channeling immunoassay and an ELISA for detecting insulin aspart in human serum.
Petersen SB; Lovmand JM; Honoré L; Jeppesen CB; Pridal L; Skyggebjerg O
J Pharm Biomed Anal; 2010 Jan; 51(1):217-24. PubMed ID: 19733992
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of an immunoassay for human-specific quantitation of therapeutic antibodies in serum samples from non-human primates.
Stubenrauch K; Wessels U; Lenz H
J Pharm Biomed Anal; 2009 May; 49(4):1003-8. PubMed ID: 19250787
[TBL] [Abstract][Full Text] [Related]
20. Validation of immunoassay for protein biomarkers: bioanalytical study plan implementation to support pre-clinical and clinical studies.
Valentin MA; Ma S; Zhao A; Legay F; Avrameas A
J Pharm Biomed Anal; 2011 Jul; 55(5):869-77. PubMed ID: 21530130
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
